Enhancer ID: | E_01_0808 |
Species: | human |
Position : | chr7:50301609-50303609 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Acute lymphoblastic leukemia (all) |
Pubmed ID: | 29977016 |
Enhancer experiment: | Chip SEQ, QRT PCR, RNA SEQ, flow cytometry |
Enhancer experiment description: | Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression.;Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression.;Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression. |
TF name : | IKZF1PAX5(ALL3,BSAP)CEBPE |
TF experiment: | ChIP-seq,qRT-PCR,RNA-Seq,????? |
TF experiment description: | Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression.;Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression.;Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression. |
Enhancer function : | Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Correspondingly, crucial B-cell development transcription factors IKZF1, PAX5, and EBF1 are also the targets of frequent somatic mutation [11, 12], highlighting that GWAS signals and somatic mutations may impact upon the same genes. The rs2239630-A risk allele is associated with increased promotor activity and CEBPE expression. |
SNP ID: | rs2239630 |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
IKZF1 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 |
PAX5 | C-MYB transcription factor network | pid | 87 |
PAX5 | ID | netpath | 38 |